6.21
price up icon5.25%   0.31
 
loading
Precedente Chiudi:
$5.90
Aprire:
$6.03
Volume 24 ore:
3.71M
Relative Volume:
1.10
Capitalizzazione di mercato:
$1.51B
Reddito:
$386.15M
Utile/perdita netta:
$-56.39M
Rapporto P/E:
-27.00
EPS:
-0.23
Flusso di cassa netto:
$-55.19M
1 W Prestazione:
+3.85%
1M Prestazione:
+2.81%
6M Prestazione:
+66.94%
1 anno Prestazione:
+18.51%
Intervallo 1D:
Value
$5.92
$6.30
Intervallo di 1 settimana:
Value
$5.73
$6.30
Portata 52W:
Value
$3.21
$6.78

Ardelyx Inc Stock (ARDX) Company Profile

Name
Nome
Ardelyx Inc
Name
Telefono
510-745-7047
Name
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Name
Dipendente
395
Name
Cinguettio
@ardelyx
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
ARDX's Discussions on Twitter

Confronta ARDX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ARDX
Ardelyx Inc
6.21 1.43B 386.15M -56.39M -55.19M -0.23
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.04 113.14B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
741.29 78.49B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
877.94 54.76B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
397.55 54.51B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
197.01 41.64B 447.02M -1.18B -906.14M -6.1812

Ardelyx Inc Stock (ARDX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-09-03 Ripresa Raymond James Strong Buy
2025-06-18 Ripresa H.C. Wainwright Buy
2025-05-02 Downgrade Raymond James Strong Buy → Outperform
2025-03-07 Ripresa Ladenburg Thalmann Buy
2025-03-04 Iniziato BTIG Research Buy
2024-11-11 Downgrade H.C. Wainwright Buy → Neutral
2024-07-02 Downgrade Piper Sandler Overweight → Neutral
2024-04-05 Iniziato Leerink Partners Outperform
2023-12-18 Iniziato Raymond James Strong Buy
2023-09-07 Iniziato H.C. Wainwright Buy
2023-08-25 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2023-03-03 Aggiornamento Wedbush Neutral → Outperform
2022-11-17 Aggiornamento Piper Sandler Neutral → Overweight
2022-05-06 Downgrade Cantor Fitzgerald Overweight → Neutral
2021-12-01 Aggiornamento Ladenburg Thalmann Neutral → Buy
2021-10-14 Downgrade Ladenburg Thalmann Buy → Neutral
2021-07-21 Downgrade Jefferies Buy → Hold
2021-07-20 Downgrade Piper Sandler Overweight → Neutral
2021-07-20 Downgrade Wedbush Outperform → Neutral
2021-03-23 Iniziato Wedbush Outperform
2021-01-06 Iniziato Cantor Fitzgerald Overweight
2020-10-20 Ripresa Citigroup Buy
2020-02-18 Ripresa Jefferies Buy
2020-02-12 Iniziato Citigroup Buy
2020-02-10 Iniziato Cowen Outperform
2019-04-08 Iniziato Piper Jaffray Overweight
2018-08-24 Iniziato Jefferies Buy
2018-03-19 Ripresa Leerink Partners Outperform
2017-11-29 Reiterato Citigroup Buy
2017-11-22 Reiterato Ladenburg Thalmann Buy
2017-10-17 Ripresa Leerink Partners Outperform
2016-03-31 Iniziato Ladenburg Thalmann Buy
2016-03-09 Iniziato Cantor Fitzgerald Buy
2016-03-03 Iniziato Citigroup Buy
Mostra tutto

Ardelyx Inc Borsa (ARDX) Ultime notizie

pulisher
07:34 AM

Ardelyx, Inc.'s (NASDAQ:ARDX) Path To Profitability - simplywall.st

07:34 AM
pulisher
Dec 12, 2025

Ardelyx stock price target raised to $16 from $15 at Raymond James - Investing.com Australia

Dec 12, 2025
pulisher
Dec 12, 2025

Should You Allocate More Funds to Kesar Enterprises Limited in YEARDay Trading Setups & Free Popular Stock Picks Selection - earlytimes.in

Dec 12, 2025
pulisher
Dec 11, 2025

Aug Swings: Will Ardelyx Inc stock benefit from AI adoptionTrade Volume Summary & Accurate Intraday Trading Signals - moha.gov.vn

Dec 11, 2025
pulisher
Dec 07, 2025

Marshall Wace LLP Raises Stock Position in Ardelyx, Inc. $ARDX - MarketBeat

Dec 07, 2025
pulisher
Dec 05, 2025

Ardelyx, Inc. $ARDX Shares Sold by Two Seas Capital LP - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

Stonepine Capital Management LLC Acquires New Stake in Ardelyx, Inc. $ARDX - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

What catalysts could drive Ardelyx Inc. stock higherJuly 2025 Action & Precise Swing Trade Entry Alerts - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Can Ardelyx Inc. stock rebound after recent weaknessEarnings Performance Report & Risk Controlled Stock Pick Alerts - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Why Ardelyx Inc. stock could see breakout soon2025 Trading Volume Trends & Precise Trade Entry Recommendations - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Ardelyx (ARDX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 04, 2025
pulisher
Dec 04, 2025

Can Ardelyx Inc. stock maintain operating marginsPortfolio Value Report & AI Powered Market Trend Analysis - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

ARDX SEC FilingsArdelyx 10-K, 10-Q, 8-K Forms - Stock Titan

Dec 03, 2025
pulisher
Dec 03, 2025

Irritable Bowel Syndrome (IBS) Treatment Market Competition Analysis 2025: How Players Are Shaping Growth - EIN News

Dec 03, 2025
pulisher
Dec 03, 2025

Capital Fund Management S.A. Boosts Position in Ardelyx, Inc. $ARDX - MarketBeat

Dec 03, 2025
pulisher
Dec 02, 2025

Ardelyx Inc. Reports Strong Q3 Earnings Growth - MSN

Dec 02, 2025
pulisher
Dec 02, 2025

Can Ardelyx Inc. stock surprise with earnings upsideWeekly Trade Recap & High Accuracy Investment Entry Signals - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Will Ardelyx Inc. (41X) stock keep high P E multiplesInsider Selling & Expert-Curated Trade Recommendations - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Is Ardelyx Inc. (41X) stock overpriced at current multiplesAnalyst Upgrade & Proven Capital Preservation Methods - Newser

Dec 02, 2025
pulisher
Dec 01, 2025

Fundamentals Check: Is Ardelyx Inc 41X stock overpriced at current multiples2025 Bull vs Bear & Weekly High Return Forecasts - BỘ NỘI VỤ

Dec 01, 2025
pulisher
Dec 01, 2025

Aug Catalysts: How Ardelyx Inc 41X stock reacts to fiscal policiesQuarterly Risk Review & Verified High Yield Trade Plans - BỘ NỘI VỤ

Dec 01, 2025
pulisher
Nov 30, 2025

Virtus Investment Advisers LLC Purchases 50,946 Shares of Ardelyx, Inc. $ARDX - MarketBeat

Nov 30, 2025
pulisher
Nov 29, 2025

Will Ardelyx Inc. stock deliver strong dividend growthJuly 2025 Decliners & Real-Time Volume Analysis Alerts - moha.gov.vn

Nov 29, 2025
pulisher
Nov 28, 2025

Universal Beteiligungs und Servicegesellschaft mbH Cuts Holdings in Ardelyx, Inc. $ARDX - MarketBeat

Nov 28, 2025
pulisher
Nov 27, 2025

Ardelyx (ARDX) Q3 2025 Earnings Call Transcript - Nasdaq

Nov 27, 2025
pulisher
Nov 27, 2025

How Ardelyx Inc. (41X) stock reacts to weak economyQuarterly Portfolio Report & Stock Market Timing Techniques - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 27, 2025

Ardelyx, Inc. Stock Soars 20.96%, Hits Intraday High of $6.73 - Markets Mojo

Nov 27, 2025
pulisher
Nov 27, 2025

Ardelyx, Inc. (NASDAQ:ARDX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Nov 27, 2025
pulisher
Nov 26, 2025

Raymond James raises Ardelyx stock price target to $15 on strong Ibsrela growth By Investing.com - Investing.com South Africa

Nov 26, 2025
pulisher
Nov 26, 2025

Ardelyx (NASDAQ:ARDX) Insider Sells $35,600.04 in Stock - MarketBeat

Nov 26, 2025
pulisher
Nov 25, 2025

[Form 4] ARDELYX, INC. Insider Trading Activity - Stock Titan

Nov 25, 2025
pulisher
Nov 25, 2025

Ardelyx Executives Sell Shares to Cover Taxes - TradingView

Nov 25, 2025
pulisher
Nov 25, 2025

Ardelyx Insider Sold Shares Worth $259,609, According to a Recent SEC Filing - marketscreener.com

Nov 25, 2025
pulisher
Nov 25, 2025

Ardelyx insider Form 4 details 46,887-share RSU tax sale - Stock Titan

Nov 25, 2025
pulisher
Nov 25, 2025

Officer Williams Surrenders 6,426 Of Ardelyx Inc [ARDX] - TradingView

Nov 25, 2025
pulisher
Nov 25, 2025

Market Sentiment Around Loss-Making Ardelyx, Inc. (NASDAQ:ARDX) - 富途牛牛

Nov 25, 2025
pulisher
Nov 25, 2025

Raymond James raises Ardelyx stock price target to $15 on strong Ibsrela growth - Investing.com

Nov 25, 2025
pulisher
Nov 23, 2025

Ardelyx Inc Stock Analysis and ForecastEarnings Season Recap & Affordable Stock Picks - earlytimes.in

Nov 23, 2025
pulisher
Nov 21, 2025

Ardelyx price target raised to $10 from $9 at Piper Sandler - MSN

Nov 21, 2025
pulisher
Nov 21, 2025

How Ardelyx Inc. stock reacts to job market dataIndex Update & Proven Capital Preservation Methods - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is Ardelyx Inc. (41X) stock ideal for retirement investorsMarket Activity Recap & Technical Analysis for Trade Confirmation - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Officer Williams Files To Sell 6,354 Of Ardelyx Inc [ARDX] - TradingView

Nov 20, 2025
pulisher
Nov 20, 2025

Officer Reilly Files To Sell 10,845 Of Ardelyx Inc [ARDX] - TradingView

Nov 20, 2025
pulisher
Nov 20, 2025

Will Ardelyx Inc. stock gain from government policiesJuly 2025 Review & AI Enhanced Trade Execution Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How Ardelyx Inc. stock valuations compare to rivalsDollar Strength & Long-Term Capital Growth Strategies - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Traders Buy Large Volume of Ardelyx Call Options (NASDAQ:ARDX) - MarketBeat

Nov 20, 2025
pulisher
Nov 20, 2025

BTIG Maintains a Buy on Ardelyx, Inc (ARDX) - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

Combining machine learning predictions for Ardelyx Inc.July 2025 Outlook & Short-Term Trading Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

What momentum indicators show for Ardelyx Inc. stockJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com

Nov 20, 2025

Ardelyx Inc Azioni (ARDX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Ardelyx Inc Azioni (ARDX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
RAAB MICHAEL
President & CEO
Nov 21 '25
Sale
5.54
46,887
259,609
1,455,363
Kelliher Mike
See Remarks
Nov 21 '25
Sale
5.54
5,560
30,785
271,181
Williams Laura A
Chief Patient Officer
Nov 21 '25
Sale
5.54
6,426
35,580
359,896
Foster Eric Duane
Chief Commercial Officer
Nov 21 '25
Sale
5.54
5,814
32,192
295,684
Reilly Joseph James
See Remarks
Nov 21 '25
Sale
5.54
11,086
61,382
108,914
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Capitalizzazione:     |  Volume (24 ore):